Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights
Reviva Pharmaceuticals – Favorable long-term safety and robust broad-spectrum efficacy sustained over 1-year for once daily brilaroxazine in open-label extension...
Reviva
